Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic dopamine receptor stimulation using bromocriptine: failure to modify thyroid function.

J Köbberling, A Darragh, E Del Pozo

    Clinical Endocrinology
    |October 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Restoration of fertility in prolactin induced premature menopause : A report of an eight year case study.

    Irish journal of medical science·2016
    Same author

    Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers.

    Irish journal of medical science·2016
    Same author

    Trends in the dispensation of antidepressant drugs over the past decade (2000-2010) in Andalusia, Spain.

    Social psychiatry and psychiatric epidemiology·2014
    Same author

    Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.

    European journal of pain (London, England)·2013
    Same author

    Pressure waves in the aorta during isolated abdominal belt loading: the magnitude, phasing, and attenuation.

    Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2011
    Same author

    Myalgic encephalomyelitis: International Consensus Criteria.

    Journal of internal medicine·2011

    Bromocriptine, a dopamine agonist, did not affect thyroid function in normal volunteers or acromegalic patients. This study found no significant changes in thyroid-stimulating hormone (TSH) levels or thyroid hormone regulation with bromocriptine treatment.

    Area of Science:

    • Endocrinology
    • Neuroendocrinology

    Background:

    • Bromocriptine is a dopamine agonist with known effects on the hypothalamic-pituitary axis.
    • Thyroid function is regulated by the hypothalamic-pituitary-thyroid axis, influenced by various neurotransmitters.

    Purpose of the Study:

    • To investigate the effect of bromocriptine on thyroid-stimulating hormone (TSH) secretion and thyroid hormone levels.
    • To determine if dopaminergic therapy with bromocriptine impacts thyroid function in normal individuals and acromegalic patients.

    Main Methods:

    • Administration of acute (2.5 mg) and chronic (7.5-50 mg/day) bromocriptine to normal volunteers and acromegalic subjects.
    • Measurement of plasma TSH response to thyrotropin-releasing hormone (TRH) injections.
    • Assay of thyroxine Binding Index (TBI), T3, and T4 levels.

    Related Experiment Videos

    Main Results:

    • Acute bromocriptine administration blunted the TSH response to a high dose (200 µg) of TRH in normal volunteers (P < 0.01).
    • Chronic bromocriptine treatment did not alter basal plasma TSH or the TSH response to TRH in acromegalic patients.
    • Thyroid hormone levels (T3, T4) and TBI remained unaffected by bromocriptine treatment in both groups.

    Conclusions:

    • Chronic dopaminergic therapy with bromocriptine does not appear to significantly alter overall thyroid function.
    • Acute administration of bromocriptine may modulate TSH release, but this effect does not translate to chronic changes in thyroid status.